Positive interim data from phase II trial of KRN-23 as treatment of tumor-induced osteomalacia April 22, 2016
Phase IIb/III study of bimagrumab in sporadic inclusion body myositis misses primary endpoint April 21, 2016
Scientists steer ligand bias between beta-arrestin 2 and G protein pathway for biased CXCR3 agonists April 19, 2016
RSS